Evidence map›Paper›PMID 39391113›Full record

ArticleJournal of community hospital internal medicine perspectives2024

IgA Nephropathy Secondary to COVID-19 Infection - A Case Report.

Sanjivani Shrestha, Sumanth K Bandaru, Man K Michael Siu, Silvia Malvica, Joselito Cabacar

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of community hospital internal medicine perspectives, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sanjivani ShresthaDepartment of Nephrology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Sumanth K BandaruDepartment of Internal Medicine, MedStar Health, Baltimore, MD, USA.
Man K Michael SiuDepartment of Nephrology, University of California, Irvine, CA, USA.
Silvia MalvicaDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Joselito CabacarDepartment of Nephrology, Washington Nephrology, Baltimore, MD, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a case of a 73-year-old African American lady with COVID-19 infection who developed acute Kidney Injury (AKI) and significant proteinuria. Renal biopsy showed IgA nephropathy. Patient was eventually diagnosed with IgA nephropathy secondary to COVID Infection. This unique case highlights the complexity of renal involvement in COVID-19. Notably, the onset of IgA nephropathy in the patient occurred several weeks after her COVID-19 diagnosis, deviating from the typical synpharyngitic presentation. This article contributes to the growing body of evidence regarding renal complications associated with COVID-19 and highlights the need for vigilance in assessing and managing renal conditions in COVID-19 patients, especially when atypical presentations occur.

Indexed as

COVID-19COVID nephropathyFocal segmental glomerulosclerosisFSGSIgA nephropathyRenal

Identifiers

PMID39391113
PMCPMC11464053

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.